The Primary-Care Path to HCV Cure

Infectious Diseases
Curriculum:
The Primary-Care Path to HCV Cure
Credits:
1.25 AMA PRA Category 1 Credit(s) 1.25 AANP Contact Hours 0.25 Pharmacology
Launch Date:
November 30, 2021
Expiration Date:
November 30, 2022

Primary Audience:

Primary care providers, MD, DO, Nurse Practitioners, Physician Assistants, Nurses, Addiction Specialists, Case Managers, Pharmacists

Relevant Terms:

Hepatitis C, hep C, HCV, viral hepatitis, liver disease, Simplified HCV treatment guidelines, Substance use disorder, injection drug use, Opioid epidemic, Harm reduction, Addiction medicine

Stacey B. Trooskin, MD, PhD, MPH

Chief Medical Officer and Director of Viral Hepatitis Programs
Philadelphia FIGHT Community Health Centers
Clinical Assistant Professor of Medicine
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

Dr. Stacey B. Trooskin is Chief Medical Officer and Director of Viral Hepatitis Programs at Philadelphia FIGHT Community Health Centers and is a faculty member of the Infectious Diseases Division at the University of Pennsylvania. Dr. Trooskin received her MPH in Public Health from Yale University, her PhD (Epidemiology) from Rutgers School of Public Health and her MD from the University of Medicine and Dentistry of New Jersey, at the Robert Wood Johnson School of Medicine. Dr. Trooskin specializes in infectious diseases, HIV medicine, HIV/HCV co-infection, and internal medicine.  She has an interest in public health, particularly the epidemiology of hepatitis C and identifying and overcoming barriers to testing and treatment. She recently completed a 3 year term of service as a member of the AASLD/IDSA HCV treatment guidance panel and currently serves as the Chief Medical Advisor to the National Viral Hepatitis Roundtable and is a member of the Technical Advisory Board (TAB) of the Coalition for Global Hepatitis Elimination.

1. Demonstrate a comprehensive understanding of the HCV care continuum
2. Apply Centers for Disease Control and Prevention (CDC) guidelines for HCV universal screening and risk-based testing
3. Utilize AASLD/IDSA simplified HCV treatment guidelines
4. Provide patient education, counseling, and support across the HCV care continuum, encompassing harm-reduction principles and practices

TITLE: Treating Hepatitis C in the Primary Care Setting: Establishing Clinical Readiness Through Mentored Learning

COMPONENT 2: On-demand Enduring Activity

CREDITS: 1.25 AMA PRA Category 1 Credit™ or 1.25 AANP Contact Hour (which includes 0.25 hour(s) of pharmacology)

LAUNCH DATE: November 30, 2021

EXPIRATION DATE: November 30, 2022

PRIMARY AUDIENCE: Primary care physicians, NPs, PAs, and other clinicians involved in the care of patients with or at risk of HCV infection

RELEVANT TERMS: HCV, hepatitis C, hepatitis C virus, HCV infection, hep C, primary care, PCP

COURSE FACULTY

Stacey B. Trooskin, MD, PhD, MPH
Chief Medical Officer
Philadelphia FIGHT
Clinical Assistant Professor of Medicine
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

LEARNING OBJECTIVES

Upon completion of this activity, the participant should be better able to:

  • Demonstrate a comprehensive understanding of the HCV care continuum
  • Apply Centers for Disease Control and Prevention (CDC) guidelines for HCV universal screening and risk-based testing
  • Utilize AASLD/IDSA simplified HCV treatment guidelines
  • Provide patient education, counseling, and support across the HCV care continuum
  • Promote harm-reduction principles and practices

COURSE SUMMARY

This online, interactive curriculum will provide continuing education (CME/CE) for primary care providers (PCPs) to support their competence and confidence in treating patients with chronic hepatitis C virus (HCV) infection. Small-group workshops will utilize novel collaborative-education methodologies, facilitate peer-to-peer learning, and promote sharing of strategies for overcoming challenges inherent to adoption of new clinical practices.

PLANNING COMMITTEE

Michelle Frisch, MPH, CHCP
Vice President, Operations
National Association for Continuing Education
Plantation, FL

Angela Golden, DNP, FNP-C, FAANP
NP Obesity Treatment Clinic
NP from Home, LLC
Assistant Professor (Ret), Northern Arizona University
Past President, American Association of Nurse Practitioners
Munds Park, AZ

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL

Jeanette Ruby, MD
Vice President, Scientific Services
Integritas Communications Group
Hoboken, NJ

Jim Kappler, PhD
Integritas Communications Group
Hoboken, NJ

Becky Carney, MSPT
Senior VP, Educational Strategy
Integritas Communications Group
Hoboken, NJ

Christa Master
Vice President, Account Services
Integritas Communications Group
Hoboken, NJ

ACCREDITATION INFORMATION

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and Integritas Communications. NACE is accredited by the ACCME to provide continuing medical education for physicians.

NACE designates this enduring activity for 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and Integritas Communications.  The NACE is accredited by AANP as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 1.25 contact hours (which includes 0.25 hour(s) of pharmacology).

DISCLOSURE POLICY

Accredited education provided by the National Association for Continuing Education (NACE) must demonstrate balance, independence, objectivity, and scientific rigor. All individuals in a position to influence content of NACE accredited education are required to disclose all financial relationships with ineligible companies within the previous 24-month period, regardless of relevance to the education. All relevant financial relationships and potential conflicts of interest will be mitigated prior to the activity.

NACE defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

INDIVIDUAL DISCLOSURES

Course Faculty

Stacey B. Trooskin, MD, PhD, MPH: Advisory Board Member: Gilead Sciences Contracted Research: Gilead Sciences

Dr. Trooskin’s relevant financial relationships have been mitigated.

Planning Committee

Michelle Frisch, MPH, CHCP: No financial relationships to disclose

Angela Golden, DNP, FNP-C, FAANP: No financial relationships to disclose

Gregg Sherman, MD: No financial relationships to disclose

Jeanette Ruby, MD: No financial relationships to disclose

Jim Kappler, PhD: No financial relationships to disclose

Becky Carney, MSPT: No financial relationships to disclose

Christa Master: No financial relationships to disclose

STATEMENT OF COMMERCIAL SUPPORT

This activity is supported by an independent educational grant from Gilead Sciences, Inc.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must complete the posttest and program evaluation. Your posttest will automatically be graded. If you successfully complete the posttest (score of 75% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

COURSE VIEWING REQUIREMENTS

Supported Browsers:
Microsoft Edge
Google Chrome 60 or higher
Mozilla Firefox 60 or higher
Apple Safari 11.0 or higher
For video, install the latest version of Quicktime.
Supported Phones & Tablets:
iOS 9.3 and higher
Android 7.0 (Nougat or higher)
Microsoft Windows 8
Chrome OS

 
Additional Recommendations and Requirements
Display Resolution & Color Depth Resolution
- 960 X 768 minimum
- 1024 X 768 recommended min.

Color Depth
- 8 bits (256 colors) minimum
- 16 bits (High colors) minimum
Audio - Microphone
- Speakers or headphones
- Audio recording support
Word Processing Software that can open, modify, and save documents in Rich Text Format (RTF). Microsoft Word and PowerPoint are recommended.